MorphoSys AG

560 articles about MorphoSys AG

• MorphoSys AG Expands Japanese Alliance With GeneFrontier Corporation

  1/25/2007

• MorphoSys AG Enlarges Therapeutic Antibody Collaboration With Pfizer Inc. - Expansion Doubles Potential Deal Volume For MorphoSys AG

  12/20/2006

• MorphoSys AG Presents New RapMAT(TM) Antibody Technology

  12/11/2006

• MorphoSys AG And The Burnham Institute Sign Broad Research Partnership

  11/28/2006

• MorphoSys AG And Boehringer Ingelheim Corporation Expand Collaboration With New Cancer-Related Antibody Program

  11/13/2006

• MorphoSys AG And U.S. Army Enter Into Biodefense Cooperation - MorphoSys AG's AbD Serotec Awarded Sole Supplier Contract To USAMRIID

  9/25/2006

• Crucell N.V. And DSM Biologics Announce Second PER.C6 Licensing Agreement With MorphoSys AG

  8/17/2006

• AbD Serotec Opens New U.S. Office In Research Triangle Region

  8/4/2006

• MorphoSys AG Announces Expansion Of Collaboration With Novartis Corporation

  6/26/2006

• MorphoSys AG And Schering-Plough Corporation Sign R&D Agreement

  5/17/2006

• MorphoSys AG And Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance To Develop Novel Antibody Therapies

  3/16/2006

• MorphoSys AG And Roche Expand Therapeutic Antibody Partnership; MorphoSys To Receive Up To $10 Million EURO

  3/1/2006

• MorphoSys AG Achieves Fourth Therapeutic Milestone In Centocor, Inc. Collaboration

  3/1/2006

• MorphoSys AG Updates Strategy For Proprietary Product Development

  2/23/2006

• MorphoSys AG Acquires Serotec Group To Strengthen Global Research Antibody Business

  1/12/2006

• CHEMICON International, Inc. And MorphoSys AG Enter Into Worldwide Licensing Agreement For Research Antibodies

  1/10/2006

• MorphoSys AG Enters Antibody Pact With U.S. Merck & Co., Inc.

  12/14/2005

• MorphoSys AG Reports Third Quarter 2004 Results

  10/28/2004

• A Look Back At June In Biotech

  7/12/2004

• MorphoSys AG Reports First Quarter 2004 Results

  4/29/2004